Bruce Seet

Dr. Bruce Seet brings his diverse background and experience to the Department of Molecular Genetics to enhance the professional development of graduate-level trainees. Bruce earned a B.Sc (Honours Human Physiology) and a Ph.D. (Microbiology and Immunology) from Western University (London, Canada), followed by a postdoctoral research fellowship at the Lunenfeld Research Institute at Mt. Sinai Hospital (Toronto). After a decade of research in academia, Dr. Seet joined GlaxoSmithKline (GSK) in 2006 where he held a variety of roles over 8 years. While at GSK, he completed his MBA at the Rotman School of Management (Toronto). In 2014, he joined Sanofi Pasteur and served as the Director of Medical Affairs. Recently, in 2022, joined Novavax as Head of Medical Affairs in Canada.

Among his volunteer activities, Bruce serves as a mentor and coach to young scientists and is the President and founder of the Science to Business Network (www.s2bn.org), a grass-roots organization formed in 2011 that promotes the professional development of young scientists as well as innovation in Canada by connecting industry and academia. He also serves on the Research Management Committee as well as the HQP Development Committee for BioCanRx, a Network Centres of Excellence (NCE) that accelerates the clinical development of promising cancer immunotherapies in Canada.